These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18096454)

  • 21. Profiles of Foxp3+ regulatory T cells in eczematous dermatitis, psoriasis vulgaris and mycosis fungoides.
    Fujimura T; Okuyama R; Ito Y; Aiba S
    Br J Dermatol; 2008 Jun; 158(6):1256-63. PubMed ID: 18363755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of increased CD4+CD25-Foxp3+ T cells in patients with new-onset systemic lupus erythematosus.
    Zhang B; Zhang X; Tang FL; Zhu LP; Liu Y; Lipsky PE
    Ann Rheum Dis; 2008 Jul; 67(7):1037-40. PubMed ID: 18199598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(-)CD8(-)alphabetaTCR(+) Double Negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden.
    Feyler S; von Lilienfeld-Toal M; Jarmin S; Marles L; Rawstron A; Ashcroft AJ; Owen RG; Selby PJ; Cook G
    Br J Haematol; 2009 Mar; 144(5):686-95. PubMed ID: 19133978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
    Zhang Y; Wang HB; Chi LJ; Wang WZ
    Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype.
    Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M
    Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.
    Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y
    Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype.
    Santner-Nanan B; Seddiki N; Zhu E; Quent V; Kelleher A; Fazekas de St Groth B; Nanan R
    Int Immunol; 2008 Mar; 20(3):375-83. PubMed ID: 18195049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXP3 expression in blood, synovial fluid and synovial tissue during inflammatory arthritis and intra-articular corticosteroid treatment.
    Raghavan S; Cao D; Widhe M; Roth K; Herrath J; Engström M; Roncador G; Banham AH; Trollmo C; Catrina AI; Malmström V
    Ann Rheum Dis; 2009 Dec; 68(12):1908-15. PubMed ID: 19066178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
    Eliseeva DD; Zavalishin IA; Karaulov AV; Bykovskaia SN
    Vestn Ross Akad Med Nauk; 2012; (3):68-74. PubMed ID: 22712278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of naive CD4+ T cells into CD4+CD25+FOXP3+ regulatory T cells by continuous antigen stimulation.
    Mahic M; Yaqub S; Bryn T; Henjum K; Eide DM; Torgersen KM; Aandahl EM; Taskén K
    J Leukoc Biol; 2008 May; 83(5):1111-7. PubMed ID: 18270250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor.
    Miyara M; Yoshioka Y; Kitoh A; Shima T; Wing K; Niwa A; Parizot C; Taflin C; Heike T; Valeyre D; Mathian A; Nakahata T; Yamaguchi T; Nomura T; Ono M; Amoura Z; Gorochov G; Sakaguchi S
    Immunity; 2009 Jun; 30(6):899-911. PubMed ID: 19464196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ CD25+ regulatory T cells approach the clinic.
    Edinger M
    Cytotherapy; 2008; 10(7):655-6. PubMed ID: 18985471
    [No Abstract]   [Full Text] [Related]  

  • 36. Foxp3 expression on normal and leukemic CD4+CD25+ T cells implicated in human T-cell leukemia virus type-1 is inconsistent with Treg cells.
    Abe M; Uchihashi K; Kazuto T; Osaka A; Yanagihara K; Tsukasaki K; Hasegawa H; Yamada Y; Kamihira S
    Eur J Haematol; 2008 Sep; 81(3):209-17. PubMed ID: 18510697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
    Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
    Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation.
    Hoffmann P; Boeld TJ; Eder R; Huehn J; Floess S; Wieczorek G; Olek S; Dietmaier W; Andreesen R; Edinger M
    Eur J Immunol; 2009 Apr; 39(4):1088-97. PubMed ID: 19283780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of amplification of CD4+CD25(high) regulatory T cells during in vitro expansion of tumor-infiltrating lymphocytes in melanoma patients.
    Knol AC; Lemaître F; Pandolfino MC; Volteau C; Quéreux G; Saiagh S; Khammari A; Viguier M; Dréno B
    Exp Dermatol; 2008 May; 17(5):436-45. PubMed ID: 18312383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.